TANGO THERAPEUTICS INC
TNGX · NASDAQ
Updated at 2026-10-14 10:07:00
- Today's High
- $24.11
- Today’s Low
- $21.85
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $23.57
- Previous Close
- $24.17
- Volume
- 2.86M
- Market Cap
- $4.07B
- P/E Ratio
- --
- EPS
- $-0.84
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 201 BROOKLINE AVENUE, BOSTON, MA, UNITED STATES, 02215
- Country
- US
- Listing Date
- 2020-09-03
- Fiscal Year End
- December
- Shares Outstanding
- 162.33M
- CIK
- 0001819133
- Website
- www.tangotx.com
Tango Therapeutics Inc. is a leading clinical-stage biotechnology firm at the forefront of cancer treatment innovation, specializing in synthetic lethality and targeted therapies. With a robust pipeline of promising drug candidates focused on precision oncology, the company is uniquely positioned to address critical unmet needs in cancer care. Strategic collaborations with top academic institutions bolster its research and development efforts, enhancing its ability to deliver transformative therapeutic solutions. Tango Therapeutics aims to significantly improve patient outcomes and redefine treatment paradigms in oncology, making it a compelling investment opportunity in the biopharmaceutical landscape.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$53.81M
Operating Expenses
2026-06-30
$59.78M
2026-03-31
$48.3M
2025-12-31
$41.38M
2025-09-30
$39.73M
Net Income
2026-06-30
-$55.34M
2026-03-31
-$45.51M
2025-12-31
-$38.74M
2025-09-30
$15.88M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
29.51%
Earnings Per Share
2026-06-30
$-0.37
2026-03-31
$-0.32
2025-12-31
$-0.29
2025-09-30
$0.13
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$54.91M
2026-03-31
-$45.05M
2025-12-31
-$38.32M
2025-09-30
$16.42M
Effective Tax Rate
2026-06-30
0%
2026-03-31
0%
2025-12-31
0.14%
2025-09-30
-0.06%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $53.81M |
| Operating Expenses | $59.78M | $48.3M | $41.38M | $39.73M |
| Net Income | -$55.34M | -$45.51M | -$38.74M | $15.88M |
| Net Profit Margin | -- | -- | -- | 29.51% |
| Earnings Per Share | $-0.37 | $-0.32 | $-0.29 | $0.13 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$54.91M | -$45.05M | -$38.32M | $16.42M |
| Effective Tax Rate | 0% | 0% | 0.14% | -0.06% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.